PMA supplement
N18466 S019: CMW 1 RADIOPAQUE, CMW2 AND CMW3 BONE CEMENTS
FDA PMA supplement · Normal 180 Day Track · Depuy, Inc.
Key facts
| Original PMA | N18466 |
|---|---|
| Supplement number | S019 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | CMW 1 RADIOPAQUE, CMW2 AND CMW3 BONE CEMENTS |
| Generic name | BONE CEMENT |
| Applicant | Depuy, Inc. |
| Product code | LOD |
| Received date | Sep 20, 1995 |
| Decision date | Nov 20, 1995 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: